Compare IPWR & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPWR | LNSR |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.4M | 63.5M |
| IPO Year | 2013 | 2005 |
| Metric | IPWR | LNSR |
|---|---|---|
| Price | $5.19 | $8.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $10.75 | $10.00 |
| AVG Volume (30 Days) | ★ 146.3K | 109.0K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | $2,603.56 | $10.06 |
| Revenue Next Year | $1,800.00 | $41.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $2.62 | $4.95 |
| 52 Week High | $9.30 | $12.96 |
| Indicator | IPWR | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 61.78 | 82.31 |
| Support Level | $2.92 | $5.25 |
| Resistance Level | $5.19 | $12.13 |
| Average True Range (ATR) | 0.44 | 0.37 |
| MACD | 0.15 | 0.29 |
| Stochastic Oscillator | 90.86 | 84.96 |
Ideal Power Inc is engaged in the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.